Eczema epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 2: | Line 2: | ||
{{Eczema}} | {{Eczema}} | ||
{{CMG}}, {{AE}} [[User:Edzelco|Edzel Lorraine Co, D.M.D., M.D.]] | {{CMG}}, {{AE}} [[User:Edzelco|Edzel Lorraine Co, D.M.D., M.D.]] | ||
==Overview== | |||
[[Eczema]] has been noted to have affected 1-3% of the adult population and 15-20% of the children population worldwide. <ref name="pmiddoi:10.1159/000370220.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi:10.1159/000370220. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref><ref name="pmiddoi: 10.1016/j.jaad.2013.10.010.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaad.2013.10.010. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> In the United States, prevalence is 10.7% in children, and 7.2% in adults. <ref name="pmiddoi: 10.1038/jid.2010.251.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1038/jid.2010.251. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref><ref name="pmiddoi: 10.1038/jid.2014.325.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1038/jid.2014.325. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> [[Eczema]] is more commonly observed in [[males]], particularly in those with severe cases, and has a late onset.<ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413 }} </ref> | |||
==Eczema Epidemiology and Demographics== | |||
*[[Eczema]] has been noted to have affected 1-3% of the adult population and 15-20% of the children population worldwide. | |||
*In the United States, the prevalence is 10.7% in children and 7.2% in adults. | |||
*[[Eczema]] is more commonly observed in [[males]], particularly in those with severe cases, and has a late-onset. | |||
*[[Onset]] of [[disease]] is usually at [[age]] 5 years, and a peak [[incidence]] at [[age]] 3-6 months.<ref name="pmiddoi: 10.1016/j.jaad.2013.10.010.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaad.2013.10.010. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref><ref name="pmid17498413">{{cite journal| author=Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group| title=A population-based survey of eczema prevalence in the United States. | journal=Dermatitis | year= 2007 | volume= 18 | issue= 2 | pages= 82-91 | pmid=17498413 | doi=10.2310/6620.2007.06034 | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=17498413 }} </ref> | |||
*A recent study showed that persistence of [[disease]] 8 years from the [[onset]] is noted in 20% of [[children]].<ref name="pmiddoi: 10.1016/j.jaad.2016.05.028.">{{cite journal| author=Schmoldt A, Benthe HF, Haberland G| title=Digitoxin metabolism by rat liver microsomes. | journal=Biochem Pharmacol | year= 1975 | volume= 24 | issue= 17 | pages= 1639-41 | pmid=doi: 10.1016/j.jaad.2016.05.028. | doi= | pmc= | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=10 }} </ref> | |||
==References== | ==References== |
Revision as of 01:31, 19 May 2022
Eczema Microchapters |
Diagnosis |
---|
Treatment |
Case Studies |
Eczema On the Web |
American Roentgen Ray Society Images of Eczema |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1], Associate Editor(s)-in-Chief: Edzel Lorraine Co, D.M.D., M.D.
Overview
Eczema has been noted to have affected 1-3% of the adult population and 15-20% of the children population worldwide. [1][2] In the United States, prevalence is 10.7% in children, and 7.2% in adults. [3][4] Eczema is more commonly observed in males, particularly in those with severe cases, and has a late onset.[5]
Eczema Epidemiology and Demographics
- Eczema has been noted to have affected 1-3% of the adult population and 15-20% of the children population worldwide.
- In the United States, the prevalence is 10.7% in children and 7.2% in adults.
- Eczema is more commonly observed in males, particularly in those with severe cases, and has a late-onset.
- Onset of disease is usually at age 5 years, and a peak incidence at age 3-6 months.[2][5]
- A recent study showed that persistence of disease 8 years from the onset is noted in 20% of children.[6]
References
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID doi:10.1159/000370220. Check
|pmid=
value (help). - ↑ 2.0 2.1 Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.jaad.2013.10.010. doi: 10.1016/j.jaad.2013.10.010. Check
|pmid=
value (help). - ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1038/jid.2010.251. doi: 10.1038/jid.2010.251. Check
|pmid=
value (help). - ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1038/jid.2014.325. doi: 10.1038/jid.2014.325. Check
|pmid=
value (help). - ↑ 5.0 5.1 Hanifin JM, Reed ML, Eczema Prevalence and Impact Working Group (2007). "A population-based survey of eczema prevalence in the United States". Dermatitis. 18 (2): 82–91. doi:10.2310/6620.2007.06034. PMID 17498413.
- ↑ Schmoldt A, Benthe HF, Haberland G (1975). "Digitoxin metabolism by rat liver microsomes". Biochem Pharmacol. 24 (17): 1639–41. PMID 10.1016/j.jaad.2016.05.028. doi: 10.1016/j.jaad.2016.05.028. Check
|pmid=
value (help).